Literature DB >> 21252269

Antibiotic resistance mechanisms of Vibrio cholerae.

Maya Kitaoka1, Sarah T Miyata1, Daniel Unterweger1, Stefan Pukatzki1.   

Abstract

As the causative agent of cholera, the bacterium Vibrio cholerae represents an enormous public health burden, especially in developing countries around the world. Cholera is a self-limiting illness; however, antibiotics are commonly administered as part of the treatment regimen. Here we review the initial identification and subsequent evolution of antibiotic-resistant strains of V. cholerae. Antibiotic resistance mechanisms, including efflux pumps, spontaneous chromosomal mutation, conjugative plasmids, SXT elements and integrons, are also discussed. Numerous multidrug-resistant strains of V. cholerae have been isolated from both clinical and environmental settings, indicating that antibiotic use has to be restricted and alternative methods for treating cholera have to be implemented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252269     DOI: 10.1099/jmm.0.023051-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  69 in total

1.  The time of cholera.

Authors:  David N Fisman; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

2.  Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli.

Authors:  M Moosazadeh Moghaddam; F Abolhassani; H Babavalian; R Mirnejad; K Azizi Barjini; J Amani
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

3.  Antibiotic resistance and plasmid profiling of Vibrio spp. in tropical waters of Peninsular Malaysia.

Authors:  K G You; C W Bong; C W Lee
Journal:  Environ Monit Assess       Date:  2016-02-16       Impact factor: 2.513

4.  Reviving Phage Therapy for the Treatment of Cholera.

Authors:  Sudhakar Bhandare; Joan Colom; Abiyad Baig; Jenny M Ritchie; Habib Bukhari; Muhammad A Shah; Banwarilal L Sarkar; Jingliang Su; Brendan Wren; Paul Barrow; Robert J Atterbury
Journal:  J Infect Dis       Date:  2019-02-15       Impact factor: 5.226

5.  Redefinition and Unification of the SXT/R391 Family of Integrative and Conjugative Elements.

Authors:  Audrey Bioteau; Romain Durand; Vincent Burrus
Journal:  Appl Environ Microbiol       Date:  2018-06-18       Impact factor: 4.792

Review 6.  Antimicrobial peptides in marine invertebrate health and disease.

Authors:  Delphine Destoumieux-Garzón; Rafael Diego Rosa; Paulina Schmitt; Cairé Barreto; Jeremie Vidal-Dupiol; Guillaume Mitta; Yannick Gueguen; Evelyne Bachère
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

7.  Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal.

Authors:  Geeta Shakya; Dong Wook Kim; John D Clemens; Sarala Malla; Bishnu Prasad Upadhyaya; Shyam Prakash Dumre; Sirjana Devi Shrestha; Shailaja Adhikari; Supriya Sharma; Nisha Rijal; Sanjaya K Shrestha; Carl Mason; Palpasa Kansakar
Journal:  World J Microbiol Biotechnol       Date:  2012-05-23       Impact factor: 3.312

8.  Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.

Authors:  Jeffrey H Withey; Dhrubajyoti Nag; Sarah C Plecha; Ritam Sinha; Hemanta Koley
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

9.  Gastrointestinal infections in the setting of natural disasters.

Authors:  Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

10.  Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections.

Authors:  Andrea Rinaldo; Enrico Bertuzzo; Lorenzo Mari; Lorenzo Righetto; Melanie Blokesch; Marino Gatto; Renato Casagrandi; Megan Murray; Silvan M Vesenbeckh; Ignacio Rodriguez-Iturbe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.